Open tender · Germany · Cn Standard
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Nitisinon (ATC-Code: A16AX04).
AOK Niedersachsen. Die Gesundheitskasse.
The work
Conclusion of non-exclusive discount contracts for the drug Nitisinon (ATC-Code: A16AX04) in an 'open-house-model' from 01.04.2025 to 31.03.2027.
- Must be a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) under § 4 Abs. 18 AMG.
- Contracts are non-exclusive and have uniform conditions.
- Earliest contract start is 01.04.2025.
- Submission deadline for 01.04.2025 start is 25.02.2025.
Key facts
- Contract period
- Up to 24 months, ending no later than 31.03.2027.
- Evaluation
- Lowest price (L1) among technically qualified bids
What it takes to qualify
Worth a closer look
- The text states this is not a public procurement in the sense of Directive 2014/24/EU, but a publication for transparency.
- The exact submission address is not in the provided text, only referenced as 'I.1)'.
- The text mentions a 'Vorlauf von in der Regel 35 Kalendertagen' for processing, but this is an internal note, not a bidder requirement.
Experience
- At least 1 similar work — Prior experience with pharmaceutical discount contracts is implied by the requirement to be a 'pharmazeutischer Unternehmer'.
- Experience as a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) under § 4 Abs. 18 AMG.
Certifications and registrations
Pharmazeutischer Unternehmer statusMust be a pharmaceutical entrepreneur as defined by § 4 Abs. 18 AMG.
GST registration (optional)Not mentioned in the provided text.
PAN registration (optional)Not mentioned in the provided text.
EPF registration (optional)Not mentioned in the provided text.
ESIC registration (optional)Not mentioned in the provided text.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Contract documentsRequired for those wishing to be a partner as of 01.04.2025.
- Contractual conditionsRequired for those wishing to be a partner as of 01.04.2025.